DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Compugen Ltd. (CGEN)
« Back to company indexCGEN Chatter Timeline
Stock Ticker for CGEN
Most Active Tweeters for CGEN
| User | Tweets |
|---|---|
| @thefinreviewer | 4 |
| @BlogYomi | 3 |
| @whatsonthorold2 | 2 |
| @mmahotstuff1 | 2 |
| @StockNewsWires | 1 |
Recent Tweets for CGEN
 |
@BlogYomi Comparing of OHR Pharmaceutical Inc. $CGEN https://t.co/0O1aqfdyUV March 21st 2019, 1:03pm |
 |
@mmahotstuff1 Compugen LTD. - Ordinary Shares $CGEN's Stock Is Sell After More Market Selling https://t.co/iRDHv2M1tu March 21st 2019, 12:03pm |
 |
@whatsonthorold2 Compugen LTD. - Ordinary Shares $CGEN Reports Increase in Sellers; Strong Momentum for Short Players https://t.co/hSDoMTUrS1 March 21st 2019, 12:03pm |
 |
@StockTexts $CGEN Compugen Ltd. SEC Filing: Form 20-F https://t.co/KygQQ2586a March 21st 2019, 6:03am |
|
@BlogYomi Comparing of Bio-Techne Corporation $CGEN https://t.co/9GE72QUQFJ March 20th 2019, 7:03pm |
 |
@thefinreviewer Evofem Biosciences Inc. $CGEN https://t.co/hnIW717CpL March 19th 2019, 5:03pm |
|
@BlogYomi Reviewing Ionis Pharmaceuticals Inc. $CGEN's results https://t.co/v1W9QhH0KE March 19th 2019, 4:03pm |
|
@mmahotstuff1 Time To Buy Compugen $CGEN? BidaskScore Upgrades Shares Today https://t.co/I4ziglF5MR March 18th 2019, 9:03am |
 |
@reurope_stock Analysts at BidaskScore Give Compugen $CGEN an Upgrade https://t.co/Cektnj1509 March 18th 2019, 9:03am |
 |
@UlmHi Comparing of Avid Bioservices Inc. $CGEN https://t.co/bYqG2QDys7 March 17th 2019, 11:03am |
|
@whatsonthorold2 Compugen LTD. - Ordinary Shares $CGEN’s Trend Unknown, Especially After Increased Shorts https://t.co/HziUgXP8dO March 14th 2019, 3:03pm |
 |
@StockNewsNow $CGEN Compugen Announces Issuance of Two U.S. Composition of Matter Patents for COM701, Its Lead Immuno-Oncology Pr… https://t.co/I69JhcqS6W March 12th 2019, 11:03am |
 |
@StockNewsWires $CGEN: Compugen nabs two new patents in US for COM701; shares up 4 …: https://t.co/8uUvwHLaS0 March 12th 2019, 8:03am |
 |
@MarketCurrents $CGEN - Compugen nabs two new patents in U.S. for COM701; shares up 4% premarket https://t.co/G80Oz3ReF5 March 12th 2019, 8:03am |
 |
@ProVesting $CGEN: Compugen Announces Issuance of Two US Composition of Matter …: https://t.co/qVVpE5CdBw March 12th 2019, 7:03am |
 |
@bthefirsttoknow $CGEN Compugen Announces Issuance of Two U.S. Composition of Matter Patents for COM701, Its Lead Immuno-Oncology Pr… https://t.co/hhSonS9rV3 March 12th 2019, 7:03am |
 |
@ChartMill Compared to an average industry Altman-Z score of 1.53, $CGEN is more financially solid! https://t.co/XOgRa7dpst https://t.co/F5vdh4NebU March 11th 2019, 1:03am |
|
@thefinreviewer Contrasting of Intra-Cellular Therapies Inc. $CGEN https://t.co/ctuePnL6YF March 10th 2019, 10:03pm |
|
@thefinreviewer Reviewing Titan Pharmaceuticals Inc. $CGEN's results https://t.co/eqXa8yv4H3 March 10th 2019, 9:03pm |
|
@thefinreviewer Comparing of Sage Therapeutics Inc. $CGEN https://t.co/k36XSxe2bu March 10th 2019, 8:03pm |
|
@StockNewsNow $CGEN Compugen to Present at the Cowen and Company 39th Annual Health Care Conference https://t.co/MQBwD72PnO March 5th 2019, 10:03am |
 |
@PRNewswireIL #Compugen to #Present at the #Cowen and #Company 39th #Annual #Health #Care #Conference https://t.co/MjGJ1vJGcP @CompugenInc $CGEN March 5th 2019, 7:03am |
 |
@VisualStockRSRC $CGEN - Compugen to Present at the Cowen and Company 39th Annual Health Care Conference https://t.co/Fzua3pZCdK March 5th 2019, 7:03am |
 |
@TickerReport Compugen $CGEN Rating Increased to Strong-Buy at Zacks Investment Research https://t.co/b0Y05H9NzC March 5th 2019, 3:03am |
 |
@dailypoliticaln Compugen $CGEN Rating Increased to Strong-Buy at Zacks Investment Research https://t.co/bkagDmdPO6 March 5th 2019, 3:03am |
 |
@1stOncology #Compugen Presents Update on #COM701 Phase 1 Trial at #ASCOSITC Clinical #ImmunoOncology Symposium $CGEN https://t.co/pCAGe1MjCI March 4th 2019, 2:03am |
 |
@ZolmaxNews Compugen $CGEN Stock Rating Upgraded by Zacks Investment Research https://t.co/Q2YZZBC0aa March 4th 2019, 2:03am |
 |
@TranscriptDaily Oppenheimer Comments on Compugen Ltd.’s FY2023 Earnings $CGEN https://t.co/0MMW3EEK02 March 3rd 2019, 9:03am |
 |
@stocknewstimes Oppenheimer Comments on Compugen Ltd.’s FY2023 Earnings $CGEN https://t.co/OR8FY4SRLQ March 3rd 2019, 9:03am |
|
@mmahotstuff1 Compugen $CGEN Seems to Be a Stock That BidaskScore Is Excited About; Firm Upgrades Shares https://t.co/mPm0jkJig9 March 3rd 2019, 3:03am |
|
@whatsonthorold2 Will Today’s BidaskScore Upgrade Google Compugen $CGEN Shares? https://t.co/QyMRjq9EBy March 3rd 2019, 3:03am |
 |
@bibeypost_stock Is Compugen $CGEN Now a Buy? How Analysts Rate it and Why BidaskScore Upgraded The Stock https://t.co/3suAsGCiYZ March 3rd 2019, 3:03am |
|
@reurope_stock Is Compugen $CGEN Now Worth Your Time and Dime After a Recent BidaskScore Upgrade? https://t.co/CX4EQctjwA March 3rd 2019, 3:03am |
|
@PRNewswireIL #Compugen #Presents #Update on #COM701 #Phase 1 #Trial at #ASCO-SITC #Clinical #Immuno-Oncology #Symposium https://t.co/icJbKBbSLL $CGEN March 3rd 2019, 3:03am |
 |
@bbnsnews Compugen $CGEN PT Set at $9.00 by Oppenheimer https://t.co/Ng6CflRTmX March 2nd 2019, 10:03pm |
 |
@WeekHerald Compugen Ltd. Forecasted to Earn FY2023 Earnings of -$0.83 Per Share $CGEN https://t.co/VgAxIPVEBW March 2nd 2019, 8:03pm |
 |
@TheMarketsDaily Compugen Ltd. Forecasted to Earn FY2023 Earnings of -$0.83 Per Share $CGEN https://t.co/XRE0DQ0QGm March 2nd 2019, 8:03pm |
 |
@registrarjourn Brokers Issue Forecasts for Compugen Ltd.’s Q1 2019 Earnings $CGEN https://t.co/FluloxPt8L March 2nd 2019, 5:03pm |
 |
@EnterpriseLeade Brokers Issue Forecasts for Compugen Ltd.’s Q1 2019 Earnings $CGEN https://t.co/CIVOpEEB79 March 2nd 2019, 5:03pm |
|
@bbnsnews Compugen $CGEN Given a $9.00 Price Target by Oppenheimer Analysts https://t.co/JWmmUjkcCO March 2nd 2019, 2:03pm |
 |
@dakotafinancial Compugen $CGEN Upgraded to “Strong-Buy” at Zacks Investment Research https://t.co/2Ahrgqq9ft March 2nd 2019, 12:03pm |
|
@TranscriptDaily Compugen $CGEN Upgraded at Zacks Investment Research https://t.co/sKB0UtbCKi March 2nd 2019, 12:03pm |
 |
@jamaeze RT @Crex_24: $CGEN coin was swapped into new CGEN coin. CGEN holders were credited with new CGEN coins. 1:100 ratio. #CGEN #swap @cgennetw… March 2nd 2019, 6:03am |
 |
@Crex_24 $CGEN coin was swapped into new CGEN coin. CGEN holders were credited with new CGEN coins. 1:100 ratio. #CGEN… https://t.co/9cWdZje2z5 March 2nd 2019, 5:03am |
|
@TickerReport Compugen Ltd. $CGEN to Post FY2023 Earnings of -$0.41 Per Share, Oppenheimer Forecasts https://t.co/rli7tREd8m March 2nd 2019, 4:03am |
|
@dailypoliticaln Compugen Ltd. $CGEN to Post FY2023 Earnings of -$0.41 Per Share, Oppenheimer Forecasts https://t.co/nGI3gmlh5Y March 2nd 2019, 4:03am |
|
@TheMarketsDaily Compugen $CGEN Raised to “Strong-Buy” at Zacks Investment Research https://t.co/Z1UzHpG4Eo March 1st 2019, 9:03pm |
 |
@macondailynews Compugen $CGEN Raised to “Strong-Buy” at Zacks Investment Research https://t.co/lY60JxFFpE March 1st 2019, 9:03pm |
|
@bbnsnews Analysts Issue Forecasts for Compugen Ltd.’s FY2023 Earnings $CGEN https://t.co/FDkbgiCAmr March 1st 2019, 4:03pm |
 |
@AmericanBanking Analysts Issue Forecasts for Compugen Ltd.’s FY2023 Earnings $CGEN https://t.co/GTr3mTcNE8 #stocks March 1st 2019, 4:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.